Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

PMV Pharmaceuticals Q2 EPS $(0.29) Misses $(0.27) Estimate

PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.27) by 7.41 percent.

byBenzinga Newsdesk

August 13, 2021

1 minute read

PMV Pharmaceuticals (NASDAQ:PMVP) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.27) by 7.41 percent.

JP Morgan Maintains Underweight on Clorox, Raises Price Target to $135

By Benzinga Newsdesk

Today, 3:05 AM

JP Morgan analyst Andrea Teixeira maintains Clorox (NYSE:CLX) with a Underweight and raises the price target from $126 to $135.

CLX

PreMarket Prep Stock Of The Day: Coca-Cola

By Joel Elconin

Today, 3:05 AM

Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.

Dlocal Comments On Short-Seller Report

By Benzinga Newsdesk

Today, 3:05 AM

DLocal Limited (NASDAQ:DLO, &ldquo, DLocal&rdquo, or the &ldquo, Company&rdquo, )), a technology-first payments platform enabling global enterprise merchants to connect with billions of consumers in emerging markets

DLO